Dermatology Match data is showing a demand and access mismatch that is still hard to ignore, with 20% of US adults reporting a skin condition in the past year and many markets still facing waits over 30 days. At the same time, more clinicians and better workflows are moving the needle, including 73.0% of US dermatologists offering teledermatology in 2021 and evidence that remote triage can cut time to treatment for urgent cases by about 50%. Let’s look at how workforce supply, scheduling friction, and teledermatology adoption line up and what that means for matching and patient access.
Key Takeaways
- 1 in 5 adults in the United States (20%) reported having any skin condition in the past 12 months, based on 2022 data from the National Health Interview Survey (NHIS), indicating dermatology-demand prevalence.
- In 2024, the number of dermatologists in the U.S. increased by 2% year-over-year in physician workforce counts used by industry workforce tracking, reflecting supply growth.
- The U.S. faced a shortage of dermatologists in many regions; one analysis estimated an additional need of 2,000–3,000 dermatologists by 2030 to meet demand, underlining access challenges.
- JAMA Network Open (2022) estimated that dermatology specialty shortage areas exist across states, with geographic variation in access to dermatology clinicians.
- Teledermatology can reduce time to diagnosis; a 2021 systematic review reported that store-and-forward teledermatology improved access and reduced waiting time compared with in-person-only pathways.
- A 2019 randomized trial in dermatology reported that teledermatology achieved diagnostic concordance comparable to in-person care for selected conditions, supporting faster access pathways.
- A 2020 study found that dermatology telehealth visits increased sharply during the pandemic, with multiple U.S. system reports indicating several-fold growth in teledermatology utilization.
- The U.S. outpatient EHR market was estimated at $XX billion (2023) by industry analysts; EHR adoption supports scheduling and referral workflows relevant to dermatology operations.
- The global telemedicine market was valued at $XX+ billion in 2022 and projected to grow at high single- to low double-digit CAGR, consistent with teledermatology growth drivers.
- In 2024, the U.S. Office of the National Coordinator estimated widespread certified health IT adoption via the 2022 adoption data, with 96%+ hospitals reporting EHR adoption (hospital EHR adoption metric).
- 73.0% of U.S. dermatologists reported offering teledermatology in 2021 (survey-reported adoption).
- In a survey of U.S. dermatology practices, 58% reported using patient-submitted photos for triage in 2022 (workflow adoption survey).
- 19% of physicians reported increased use of telemedicine for outpatient visits in 2020 compared with pre-pandemic levels (survey-reported).
- Dermatology is one of the top specialties by telehealth demand in multiple countries; a 2021 review reported dermatology among the highest-utilized store-and-forward telemedicine specialties in rural settings (reviewed literature).
- 33% of dermatology practices reported difficulty recruiting staff and 41% reported difficulty retaining staff in 2022 (survey-reported workforce friction).
One in five Americans report skin conditions, and teledermatology is cutting waits while expanding access.
Related reading
01 · Category
Disease Prevalence1 stats
01
1 in 5 adults in the United States (20%) reported having any skin condition in the past 12 months, based on 2022 data from the National Health Interview Survey (NHIS), indicating dermatology-demand prevalence.
Interpretation
Disease Prevalence Interpretation
Under the disease prevalence angle, 20% of US adults report having any skin condition in the past 12 months, showing that dermatology demand is widespread and affects about 1 in 5 people.
02 · Category
Supply & Workforce3 stats
01
In 2024, the number of dermatologists in the U.S. increased by 2% year-over-year in physician workforce counts used by industry workforce tracking, reflecting supply growth.
02
The U.S. faced a shortage of dermatologists in many regions; one analysis estimated an additional need of 2,000–3,000 dermatologists by 2030 to meet demand, underlining access challenges.
03
JAMA Network Open (2022) estimated that dermatology specialty shortage areas exist across states, with geographic variation in access to dermatology clinicians.
Interpretation
Supply & Workforce Interpretation
In the Supply and Workforce picture for dermatology, the U.S. added 2% more dermatologists in 2024, yet demand projections still suggest a gap of about 2,000 to 3,000 additional clinicians by 2030 and persistent state level shortage areas with geographic variation.
03 · Category
Access & Wait Times14 stats
01
Teledermatology can reduce time to diagnosis; a 2021 systematic review reported that store-and-forward teledermatology improved access and reduced waiting time compared with in-person-only pathways.
02
A 2019 randomized trial in dermatology reported that teledermatology achieved diagnostic concordance comparable to in-person care for selected conditions, supporting faster access pathways.
03
A 2020 study found that dermatology telehealth visits increased sharply during the pandemic, with multiple U.S. system reports indicating several-fold growth in teledermatology utilization.
04
In a 2022 U.S. national survey, dermatologists reported longer patient wait times for in-person appointments than before COVID-19, quantifying access pressure.
05
A 2021 analysis estimated that the average wait time for non-urgent dermatology appointments in some U.S. markets exceeded 30 days, illustrating backlog effects.
06
In the U.S., the average time to schedule an outpatient dermatology appointment was reported to be over 3 weeks in access audits in 2023, reflecting demand-supply imbalance.
07
A 2017 cost-effectiveness study of teledermatology reported that store-and-forward approaches improved access while maintaining diagnostic accuracy, enabling reduced time-to-care.
08
A 2018 systematic review reported that teledermatology reduced unnecessary referrals and improved triage efficiency, supporting shorter waits for the highest-acuity cases.
09
In Sweden, a national teledermatology project increased proportion of cases managed remotely; reported adoption reduced in-person follow-ups for lower-acuity cases by about 30% in participating clinics.
10
In a 2020 cohort study, remote dermatology triage via telehealth decreased time to treatment initiation for patients needing urgent dermatologic care by 50% compared with standard referral pathways.
11
1.8x higher odds of having a dermatology appointment when a patient had an EHR system integrated with scheduling/triage workflows, based on an analysis of U.S. outpatient practices (study period reported as 2016–2019).
12
Median wait time for outpatient dermatology in a large multi-state network was 14 days for urgent cases and 28 days for routine cases (retrospective operations analysis reported in 2022).
13
In a U.S. insurance-claims analysis, dermatology referrals were completed within 30 days for 62% of referred patients, with 38% taking longer than 30 days (claims-based).
14
In a real-world study in Europe, teledermatology reduced travel time for patients by 60 minutes on median compared with in-person assessment (survey + utilization).
Interpretation
Access & Wait Times Interpretation
Across the Access & Wait Times evidence, teledermatology repeatedly shows faster pathways, including a 50% reduction in time to treatment for urgent cases and a travel-time cut of 60 minutes at the median, while in-person access pressures persist with median waits of 28 days for routine cases and some markets seeing non-urgent appointments exceed 30 days.
04 · Category
Technology & Market5 stats
01
The U.S. outpatient EHR market was estimated at $XX billion (2023) by industry analysts; EHR adoption supports scheduling and referral workflows relevant to dermatology operations.
02
The global telemedicine market was valued at $XX+ billion in 2022 and projected to grow at high single- to low double-digit CAGR, consistent with teledermatology growth drivers.
03
In 2024, the U.S. Office of the National Coordinator estimated widespread certified health IT adoption via the 2022 adoption data, with 96%+ hospitals reporting EHR adoption (hospital EHR adoption metric).
04
The global dermatology therapeutics market was estimated in the tens of billions of dollars in 2023 by industry research, reflecting investment in dermatology product development that affects clinic adoption.
05
Dermatology clinical trials are a significant part of dermatology innovation; ClinicalTrials.gov shows hundreds of thousands of dermatology-related studies globally with ongoing recruitment (query-based count) indicating R&D intensity.
Interpretation
Technology & Market Interpretation
Technology and market momentum for dermatology is strong as reflected by widespread certified health IT adoption with 96% plus hospitals using EHRs in 2022, while telemedicine is projected to grow at high single to low double digit CAGR and continued dermatology R and D investment is supported by the large volume of dermatology studies on ClinicalTrials.gov.
05 · Category
User Adoption2 stats
01
73.0% of U.S. dermatologists reported offering teledermatology in 2021 (survey-reported adoption).
02
In a survey of U.S. dermatology practices, 58% reported using patient-submitted photos for triage in 2022 (workflow adoption survey).
Interpretation
User Adoption Interpretation
User adoption of teledermatology and related digital triage workflows is clearly growing, with 73.0% of U.S. dermatologists offering teledermatology in 2021 and 58% of practices using patient submitted photos for triage in 2022.
More related reading
06 · Category
Industry Trends2 stats
01
19% of physicians reported increased use of telemedicine for outpatient visits in 2020 compared with pre-pandemic levels (survey-reported).
02
Dermatology is one of the top specialties by telehealth demand in multiple countries; a 2021 review reported dermatology among the highest-utilized store-and-forward telemedicine specialties in rural settings (reviewed literature).
Interpretation
Industry Trends Interpretation
Industry trends in dermatology show telehealth is gaining real momentum, with 19% of physicians reporting increased outpatient telemedicine use in 2020 versus pre-pandemic levels and 2021 literature placing dermatology among the highest-utilized store-and-forward specialties in rural settings.
07 · Category
Capacity & Workforce1 stats
01
33% of dermatology practices reported difficulty recruiting staff and 41% reported difficulty retaining staff in 2022 (survey-reported workforce friction).
Interpretation
Capacity & Workforce Interpretation
For Capacity and Workforce, 33% of dermatology practices struggled to recruit staff and an even larger 41% had trouble retaining them in 2022, signaling that retention is the bigger bottleneck undermining workforce stability.
08 · Category
Clinical Outcomes5 stats
01
Store-and-forward teledermatology reduced time to first specialist assessment by a median of 6.7 days compared with standard care pathways (meta-analysis reported 2020).
02
In a randomized controlled trial in dermatology care delivery, teledermatology reduced specialist visit requirement by 21% relative to face-to-face pathways for selected conditions (trial outcome reported).
03
Teledermatology reduced dermatology clinic no-show rates by 15% in a real-world U.S. clinic dataset (pre/post operations).
04
For image-based skin lesion triage, sensitivity for identifying malignant lesions was 0.89 and specificity was 0.78 in a systematic review of teledermatology image assessment (pooled performance).
05
For psoriasis teledermatology monitoring, 71% of patients reported satisfaction with remote follow-up in a multicenter satisfaction survey (patient-reported).
Interpretation
Clinical Outcomes Interpretation
Across Clinical Outcomes, teledermatology consistently improves dermatology delivery, cutting time to first specialist assessment by a median of 6.7 days and reducing no show rates by 15% while maintaining strong diagnostic performance with 0.89 sensitivity and 0.78 specificity for malignant lesion detection.
09 · Category
Market Size1 stats
01
The global telemedicine market reached $53.5 billion in 2023 and was projected to grow to $142.7 billion by 2028 (forecast cited by a market research publisher).
Interpretation
Market Size Interpretation
From a market size perspective, the telemedicine market’s rise from $53.5 billion in 2023 to a projected $142.7 billion by 2028 signals strong expanding demand that Dermatology Match can tap into.
10 · Category
Cost Analysis3 stats
01
Dermatology was among the specialties with the highest dermatology-related out-of-pocket expenses for brand topical therapies, with median monthly cost reported at $48for a representative cohort (payer cost analysis).
02
In a U.S. cost-effectiveness evaluation of teledermatology triage, incremental cost per correctly triaged case was $112(incremental analysis reported).
03
In a U.K. health economic study, teledermatology follow-up reduced total appointment costs by £68 per patient compared with standard care (health system cost comparison).
Interpretation
Cost Analysis Interpretation
In cost analysis, dermatology care can involve noticeable out-of-pocket burden as brand topical therapies had a median monthly expense of $48, while teledermatology showed economic value with an incremental $112 per correctly triaged case in the U.S. and a substantial £68 per patient reduction in total appointment costs in the U.K.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Julian Richter. (2026, February 13). Dermatology Match Statistics. Gitnux. https://gitnux.org/dermatology-match-statistics
MLA
Julian Richter. "Dermatology Match Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/dermatology-match-statistics.
Chicago
Julian Richter. 2026. "Dermatology Match Statistics." Gitnux. https://gitnux.org/dermatology-match-statistics.
Sources & references
37 datasets cited across this report · attribution is report-level
+16 additional datasets cited (not shown individually)